Topics covered in this month’s presentation included: • Federal Circuit “computer readable medium” claim eligibility • Update on patent eligibility of isolated DNA • USPTO’s Ombudsman Program became permanent • USPTO just issued Patent No. 8,000,000Weniger lesen